As of 2026-09-11, the Relative Valuation of IGM Biosciences Inc (IGMS) is (23.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.27 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1956.8%.
The range of the Relative Valuation is (20.83) - (26.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 29.6x | 26.6x |
| Forward P/E multiples | 23.7x - 30.4x | 27.0x |
| Fair Price | (20.83) - (26.02) | (23.58) |
| Upside | -1740.5% - -2148.9% | -1956.8% |
| Date | P/E |